Petros Pharmaceuticals | S-3: Registration statement for specified transactions by certain issuers
Petros Pharmaceuticals | 8-K: Current report
Petros Pharmaceuticals | 8-K: Current report
Petros Pharmaceuticals | 8-K: Current report
Petros Pharmaceuticals | 8-K: Current report
Petros Pharmaceuticals | DEF 14A: Definitive information statements
Petros Pharmaceuticals | NT 10-Q: Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB
Petros Pharmaceuticals | 8-K: Current report
Petros Pharmaceuticals | S-3/A: Registration statement for specified transactions by certain issuers (Amendment)
Petros Pharmaceuticals | 8-K: Current report
Petros Pharmaceuticals | DEF 14A: Definitive information statements
Petros Pharmaceuticals | 8-K: Current report
Petros Pharmaceuticals | PRE 14A: Preliminary proxy statements relating to merger or acquisition
Petros Pharmaceuticals | S-3: Registration statement for specified transactions by certain issuers
Petros Pharmaceuticals | 8-K: Current report
Petros Pharmaceuticals | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Petros Pharmaceuticals | 8-K: Current report
Petros Pharmaceuticals | 8-K: Petros Pharmaceuticals Reports Third Quarter 2022 Financial Results and Corporate Update
Petros Pharmaceuticals | POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filing
Petros Pharmaceuticals | DEFA14A: Others
No Data